Cargando…

EMT is the dominant program in human colon cancer

BACKGROUND: Colon cancer has been classically described by clinicopathologic features that permit the prediction of outcome only after surgical resection and staging. METHODS: We performed an unsupervised analysis of microarray data from 326 colon cancers to identify the first principal component (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Loboda, Andre, Nebozhyn, Michael V, Watters, James W, Buser, Carolyne A, Shaw, Peter Martin, Huang, Pearl S, Van't Veer, Laura, Tollenaar, Rob AEM, Jackson, David B, Agrawal, Deepak, Dai, Hongyue, Yeatman, Timothy J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032646/
https://www.ncbi.nlm.nih.gov/pubmed/21251323
http://dx.doi.org/10.1186/1755-8794-4-9
_version_ 1782197473440169984
author Loboda, Andre
Nebozhyn, Michael V
Watters, James W
Buser, Carolyne A
Shaw, Peter Martin
Huang, Pearl S
Van't Veer, Laura
Tollenaar, Rob AEM
Jackson, David B
Agrawal, Deepak
Dai, Hongyue
Yeatman, Timothy J
author_facet Loboda, Andre
Nebozhyn, Michael V
Watters, James W
Buser, Carolyne A
Shaw, Peter Martin
Huang, Pearl S
Van't Veer, Laura
Tollenaar, Rob AEM
Jackson, David B
Agrawal, Deepak
Dai, Hongyue
Yeatman, Timothy J
author_sort Loboda, Andre
collection PubMed
description BACKGROUND: Colon cancer has been classically described by clinicopathologic features that permit the prediction of outcome only after surgical resection and staging. METHODS: We performed an unsupervised analysis of microarray data from 326 colon cancers to identify the first principal component (PC1) of the most variable set of genes. PC1 deciphered two primary, intrinsic molecular subtypes of colon cancer that predicted disease progression and recurrence. RESULTS: Here we report that the most dominant pattern of intrinsic gene expression in colon cancer (PC1) was tightly correlated (Pearson R = 0.92, P < 10(-135)) with the EMT signature-- both in gene identity and directionality. In a global micro-RNA screen, we further identified the most anti-correlated microRNA with PC1 as MiR200, known to regulate EMT. CONCLUSIONS: These data demonstrate that the biology underpinning the native, molecular classification of human colon cancer--previously thought to be highly heterogeneous-- was clarified through the lens of comprehensive transcriptome analysis.
format Text
id pubmed-3032646
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30326462011-02-03 EMT is the dominant program in human colon cancer Loboda, Andre Nebozhyn, Michael V Watters, James W Buser, Carolyne A Shaw, Peter Martin Huang, Pearl S Van't Veer, Laura Tollenaar, Rob AEM Jackson, David B Agrawal, Deepak Dai, Hongyue Yeatman, Timothy J BMC Med Genomics Research Article BACKGROUND: Colon cancer has been classically described by clinicopathologic features that permit the prediction of outcome only after surgical resection and staging. METHODS: We performed an unsupervised analysis of microarray data from 326 colon cancers to identify the first principal component (PC1) of the most variable set of genes. PC1 deciphered two primary, intrinsic molecular subtypes of colon cancer that predicted disease progression and recurrence. RESULTS: Here we report that the most dominant pattern of intrinsic gene expression in colon cancer (PC1) was tightly correlated (Pearson R = 0.92, P < 10(-135)) with the EMT signature-- both in gene identity and directionality. In a global micro-RNA screen, we further identified the most anti-correlated microRNA with PC1 as MiR200, known to regulate EMT. CONCLUSIONS: These data demonstrate that the biology underpinning the native, molecular classification of human colon cancer--previously thought to be highly heterogeneous-- was clarified through the lens of comprehensive transcriptome analysis. BioMed Central 2011-01-20 /pmc/articles/PMC3032646/ /pubmed/21251323 http://dx.doi.org/10.1186/1755-8794-4-9 Text en Copyright ©2011 Loboda et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Loboda, Andre
Nebozhyn, Michael V
Watters, James W
Buser, Carolyne A
Shaw, Peter Martin
Huang, Pearl S
Van't Veer, Laura
Tollenaar, Rob AEM
Jackson, David B
Agrawal, Deepak
Dai, Hongyue
Yeatman, Timothy J
EMT is the dominant program in human colon cancer
title EMT is the dominant program in human colon cancer
title_full EMT is the dominant program in human colon cancer
title_fullStr EMT is the dominant program in human colon cancer
title_full_unstemmed EMT is the dominant program in human colon cancer
title_short EMT is the dominant program in human colon cancer
title_sort emt is the dominant program in human colon cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032646/
https://www.ncbi.nlm.nih.gov/pubmed/21251323
http://dx.doi.org/10.1186/1755-8794-4-9
work_keys_str_mv AT lobodaandre emtisthedominantprograminhumancoloncancer
AT nebozhynmichaelv emtisthedominantprograminhumancoloncancer
AT wattersjamesw emtisthedominantprograminhumancoloncancer
AT busercarolynea emtisthedominantprograminhumancoloncancer
AT shawpetermartin emtisthedominantprograminhumancoloncancer
AT huangpearls emtisthedominantprograminhumancoloncancer
AT vantveerlaura emtisthedominantprograminhumancoloncancer
AT tollenaarrobaem emtisthedominantprograminhumancoloncancer
AT jacksondavidb emtisthedominantprograminhumancoloncancer
AT agrawaldeepak emtisthedominantprograminhumancoloncancer
AT daihongyue emtisthedominantprograminhumancoloncancer
AT yeatmantimothyj emtisthedominantprograminhumancoloncancer